| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Generation Bio Co. (GBIO) has 15 insiders with recent SEC Form 4 filings, including 4 buys and 33 sells. GBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 60.0K | - | - | |
| Dir | 30.0K | - | - | |
| Dir | 30.0K | - | - | |
| Dir | 30.0K | - | - | |
| Dir | 30.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | Rowland Charles A Jr46 | Director | Buy | 24,384 | $5.22 | $127,403.94 | +11.0% | -8.3% | -22.7% | |
| Mar 10, 2022 | Nicholson Donald William52 | Director | Buy | 10,419 | $4.73 | $49,256.93 | +5.0% | +30.1% | -24.5% | |
| Sep 29, 2021 | Rhodes Jason P78 | Director | Sell | 81,088 | $25.40 | $2,059,519.16 | -62.8% | -67.6% | -79.0% | |
| Sep 29, 2021 | Atlas Venture Associates X, L.P.88 | 10% Owner | Sell | 81,088 | $25.40 | $2,059,519.16 | -62.8% | -67.6% | -79.0% | |
| Sep 24, 2021 | Rhodes Jason P78 | Director | Sell | 134,998 | $26.02 | $3,511,992.53 | -21.7% | -67.7% | -81.2% | |
| Sep 24, 2021 | Atlas Venture Associates X, L.P.88 | 10% Owner | Sell | 134,998 | $26.02 | $3,511,992.53 | -21.7% | -67.7% | -81.2% | |
| Sep 14, 2021 | Stanton Matthew91 | Chief Scientific Officer | Sale+OE | 4,500 | $28.07 | $126,315.00 | -2.2% | -46.2% | -79.5% | |
| Sep 10, 2021 | Stanton Matthew91 | Chief Scientific Officer | Sale+OE | 3,000 | $25.97 | $77,910.00 | -0.7% | -47.0% | -79.6% | |
| Aug 23, 2021 | Stanton Matthew91 | Chief Scientific Officer | Sale+OE | 1,500 | $25.04 | $37,560.00 | -0.8% | -25.5% | -77.8% | |
| Aug 10, 2021 | Stanton Matthew91 | Chief Scientific Officer | Sale+OE | 1,500 | $22.63 | $33,943.00 | -0.3% | -7.0% | -64.2% |